Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002682 · ClinicalTrials.gov registry record · Phase 2
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00002682: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00002682 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002682, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tetracycline, and metronidazole plus antacids in patients with MALT lymphoma of the stomach.
Interventions
- DRUG Amoxicillin
- DRUG Omeprazole
- DRUG Clarithromycin
- DRUG Bismuth Subsalicylate
- DRUG Metronidazole Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 1995-08-10 |
| Est. Completion | 2001-10-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002682
The ClinicalTrials.gov registry entry for NCT00002682 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Amoxicillin is the first listed.
NCT00002682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002682 about?
NCT00002682 is a clinical study titled "Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach". RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tet...
What is the current status of trial NCT00002682?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 1995-08-10. Estimated completion is 2001-10-08.
What interventions are being tested in trial NCT00002682?
The interventions under investigation include: Amoxicillin (DRUG), Omeprazole (DRUG), Clarithromycin (DRUG), Bismuth Subsalicylate (DRUG), Metronidazole Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002682?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.